文献速递肝病

床旁超声引导容量管理及肝硬化心肌病对肝硬化急性肾损伤结局的影响

Point-of-care ultrasound (POCUS)-guided volume management and the effect of cirrhotic cardiomyopathy on acute kidney injury outcomes in cirrhosis.
PubMed 文献 · Hepatology · 2025-09-23

该研究在2023年1月至2024年11月纳入372例肝硬化合并急性肾损伤患者,采用床旁超声引导容量管理并评估肝硬化心肌病(CCM)对AKI逆转、肾脏替代治疗需求及生存的影响。结果显示CCM可预测HRS-AKI患者不良结局、RRT需求及死亡率。

要点

  • 床旁超声引导容量管理有助于肝硬化AKI患者的容量评估与AKI逆转。
  • CCM可预测HRS-AKI患者90天和1年死亡率。
  • 心脏指数和室间隔e'速度可预测肾脏替代治疗需求。

核心结论

  • 床旁超声有助于肝硬化患者的容量管理并促进AKI逆转。
  • 肝硬化心肌病可预测HRS-AKI患者的不良结局、肾脏替代治疗需求及死亡率。

研究设计与样本

  • 研究纳入2023年1月至2024年11月间372例肝硬化合并AKI患者,其中男性84.7%,年龄50.3±12岁,MELD-Na 23.9±5.1。
  • 排除结构性心脏病、门肺高压、急性静脉曲张出血及感染性休克患者。
  • 床旁超声在ICU入科时(Time zero)、24小时、48小时、72小时及按需进行,以指导容量管理并测定下腔静脉指数和心脏指数。
  • CCM定义为4项变量中≥3项满足:室间隔e'速度、E/e'积分、左心房容积指数、三尖瓣反流速度。

主要发现

  • Time zero时低血容量、等血容量和高血容量分别为296例(79.6%)、42例(11.3%)和34例(9.1%)。
  • 床旁超声引导容量管理后,231例(62%)为肾前性AKI,61例(16.4%)为HRS-AKI,25例(6.7%)为HRS-AKD,32例(8.6%)为HRS-CKD,23例(6.2%)为多因素病因。
  • CCM总诊断率为34.7%,肾前性AKI中为32.9%,HRS-AKI中为75.4%,HRS-AKD中为28%(p<0.001)。
  • MAP 0h较高(aHR 1.9,95% CI 1.96-2,p=0.039)和心脏指数0h较高(aHR 1.2,95% CI 1.1-1.3,p=0.005)预测第7天AKI逆转。
  • 53/372例(14.2%)接受RRT;总体肺水肿发生率为4.8%,CCM患者中为5.4%。

关键数值与推荐

  • CCM诊断标准:4项变量中≥3项满足,包括室间隔e'速度、E/e'积分、左心房容积指数、三尖瓣反流速度。

临床怎么用

  • 对肝硬化合并AKI患者,可采用床旁超声评估容量状态并指导容量管理。
  • 应评估肝硬化心肌病,其有助于识别HRS-AKI高危患者及预测RRT需求和死亡风险。
  • 心脏指数和室间隔e'速度可作为预测RRT需求的参考指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Point-of-care ultrasound (POCUS) helps in assessing volume status and cirrhotic cardiomyopathy (CCM). We evaluated POCUS-guided volume management and explored clinical predictors, including CCM, of acute kidney injury (AKI) reversal, need for renal replacement therapy (RRT), and survival in cirrhosis and AKI between January 2023 and November 2024. Exclusions were patients with structural cardiac disease, portopulmonary hypertension, acute variceal bleeding, and septic shock. APPROACH AND RESULTS: POCUS was performed at ICU (intensive care unit) admission (Time zero ), 24 hours, 48 hours, 72 hours, and as needed to guide volume management and determine IVC indices and cardiac index. CCM was defined by ≥3 of 4 variables (septal e' velocity, E/e' integral, left atrial volume index, tricuspid regurgitant velocity); clinical data were collected.In all, 372 patients with AKI (84.7% men, aged 50.3±12 years, MELD-Na 23.9±5.1); 296 (79.6%), 42 (11.3%), and 34 (9.1%) were classified as hypovolemic, euvolemic, and hypervolemic at Time zero . Following POCUS-guided volume management, 231 (62%) had pre-renal AKI; 61 (16.4%) had hepatorenal syndrome (HRS-AKI); 25 (6.7%) had HRS-AKD; 32 (8.6%) had HRS-CKD, while 23 (6.2%) had a multifactorial etiology. CCM was diagnosed in 34.7%, 32.9% of pre-renal AKI, 75.4% in HRS-AKI, and 28% in HRS-AKD ( p <0.001). Higher MAP 0h (aHR 1.9, 95% CI 1.96-2, p =0.039) and cardiac index 0 h (aHR 1.2, 95% CI 1.1-1.3, p =0.005) predicted AKI reversal at day 7; 53/372 (14.2%) underwent RRT. Pulmonary edema developed in 4.8% overall; in 5.4% with CCM. Overall mortality was 46 (12.4%) and 107 (28.8%) at 90 days and 1 year. CCM predicted mortality at 90 days (aHR 8.9, 95% C: 3.9-20.4, p <0.001) and 1 year (aHR 1.7, 95% CI 1.2-2.5, p= 0.007). Cardiac index (aHR 0.6, 95% CI 0.4-0.9, p =0.005), and septal e' velocity (aHR 0.5, 95% CI 0.3-0.7, p =0.010) predicted need for RRT. CONCLUSIONS: POCUS facilitates volume management and AKI reversal in cirrhosis. CCM predicts poor outcomes in HRS-AKI, need for RRT, and mortality.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Premkumar M, Kajal K, Roy A, et al. Point-of-care ultrasound (POCUS)-guided volume management and the effect of cirrhotic cardiomyopathy on acute kidney injury outcomes in cirrhosis. Hepatology. 2025. PMID: 40986890. doi:10.1097/HEP.0000000000001524

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。